Dow Chemical Co. (DOW), at its 2009 investor day on November 12, said it projects normalized earnings of $4.00-$4.50 a share in the 2012 timeframe, achieved through a mix of growth synergies and innovation, equity earnings growth, as well as restructuring and cost synergies.
The company's new portfolio is expected to deliver greater than 10% annual revenue growth as a result of its transformation to a more focused market-driven, performance-based portfolio and the Company's growing participation in emerging economies. Growth from these geographies, such as Southeast Asia, India, Latin America, China and Eastern Europe, are expected to contribute 35% of total revenue in the 2012 timeframe.
The company also projected EBITDA margin expansion from 12% over the recent past to 20% over time.
The company said that its earnings power bolstered by science-based innovation portfolio with net present value of $28 billion.
For comments and feedback: editorial@rttnews.com